Trial title

Background and study aims

A concise, layman-friendly summary of the background information and context needed to understand the trial, the trial objectives, and an outline of how these will be achieved.. Acronyms (e.g. PI instead of primary investigator, or BP instead of blood pressure) and jargon should be avoided or minimised wherever possible.

It is up to you as a trial manager to judge how much text, image, and video content you put into this section as a 'landing page', and how much you reserve to flesh out in the 'For participants' section linked below.

Who can participate?

An outline of the characteristics or medical history of the participants being sought. 

This can include geographical area if necessary, particularly when parts of the trial are taking place outside of Oxford or the UK. If multiple different types of participants are being sought, this can be framed with ‘and/or’ statements, and may be best presented in a bullet pointed format.

In some clinical trials, it may be possible to have embedded maps of sites taking part if this could aid recruitment.

This is important to cover adequately on this main page, as otherwise potentially suitable participants may not click through to the 'For participants' sub-page.

What does the study involve?

This section should outline what the participant should expect on enrolling into the study, including details such as location, number of appointments, medication prescription, and duration of follow-up. .

Partner organisations

This section should briefly mention relevant institutions who are substantially involved in their study. This could include laboratories and other study teams. The name of each of partner organisation should link to its main web page. You may also want to outline the PCCTU's role in the trial in this section.

This is a rather flexible category that may vary significantly depending on the trial, and may make sense located elsewhere in the page – or even in one of the sub-pages for participants or healthcare professionals – but could serve as a preface to the next section, which may name external staff.

In some cases there may be no such partner organisations, so this section can be removed.

(Notes on trial staff section below)

The segment below is split into separate columns detailing key staff involved in the trial. However, such teams can vary significantly in makeup; so while the headings below should indicate how staff should be grouped (trial teams, investigators, external staff), they are more a guideline than a prescription – the most rational way of arranging staff so as to minimise differences between column length (and so unnecessarily extend the length of the page) should be self-evident.

Each column should endeavour to achieve the greatest amount of consistency, including (by order of priority) names, professional titles, and headshots for as many staff as possible – this may require Oxford staff to update their profile page.

External staff should have their name link to the academic profile of their home institution, if it exists. Emails and phone numbers, if included, should follow a consistent format.

The trial logo should be included in high fidelity, preferably in a scalable vector file format. The file name should be ‘[STUDY] Logo’

Trial status: Exact wording TBC, but for example ‘Set-Up Phase’, ‘Recruiting Phase’, ‘Closed’. Can also optionally include a participant enrolment counter.

Expected End Date: The expected end date of the trial, or if closed, the actual end date. This section can be dispensed with if this is not yet clear.

Professor Lucy Yardley (University of Bristol)

Professor Debra Bick (University of Warwick)

Professor Jenny Myers (University of Manchester)

Professor Lucy Chappell (King’s College London)

Logos of funding bodies can be put here, if available – but written funding details must also be included! (See left.)   

Funding details

e.g.

NIHR Collaboration for Leadership in Applied Health Research and Care Oxford

REC number: 24/SC/0071 • IRAS number: 332333

Study period: January 2024 – July 2026

Related publications

This section should contain only details of publications related to, or arising from, the clinical trial, and should include a DOI link to the relevant online journal. Obviously, trials in early stages may not have any such publications and may dispense with this section until they do!